Explore Sol Strategies' Q3 2025 earnings call highlights. Learn about their DAT++ model, Solana growth, staking innovations, and institutional partnerships.

Another major buy was in INTELLIA THERAPEUTICS INC (NASDAQ:NTLA), with ARK purchasing 191,705 shares for around $2.18 million through its ARKK ETF. Similar to CRISPR, INTELLIA has seen increased ...